A Phase 2 Trial of Nivolumab plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer

Project: Research

StatusActive
Effective start/end date4/09/193/09/24

Keywords

  • clinical trial
  • treatment efficacy
  • prostate cancer
  • phase 2 study